Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Outpatient pelvic lymph node dissection

J L Mohler1

  • 1Department of Surgery, University of North Carolina at Chapel Hill, USA.

The Journal of Urology
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saturated fat intake and prostate cancer aggressiveness: results from the population-based North Carolina-Louisiana Prostate Cancer Project.

Prostate cancer and prostatic diseases·2016
Same author

Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy.

Prostate cancer and prostatic diseases·2015
Same author

American College of Radiology Appropriateness Criteria(®)--locally advanced (high-risk) prostate cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2011
Same author

Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer.

BJU international·2004
Same author

Isolation and partial characterization of an epithelial cell line (RPE-F344) from the regenerating prostate of a normal adult male rat.

Prostate cancer and prostatic diseases·2002
Same author

Establishment of short-term primary human prostate xenografts for the study of prostate biology and cancer.

The American journal of pathology·2001
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

This study introduces an outpatient pelvic lymph node dissection technique for prostate cancer staging. This minimally invasive approach offers a safe and effective alternative to traditional methods, reducing hospitalization and costs.

Area of Science:

  • Urology
  • Surgical Oncology

Background:

  • Pelvic lymph node dissection is crucial for staging prostate cancer.
  • Laparoscopic techniques present challenges like a steep learning curve and high costs.

Purpose of the Study:

  • To modify pelvic lymph node dissection for outpatient performance.
  • To establish a less invasive and more cost-effective staging procedure.

Main Methods:

  • Pelvic lymph node dissection performed via bilateral 3 cm incisions in the obturator fossa.
  • Procedure conducted on 11 patients.

Main Results:

  • 11 patients underwent the procedure, with 5-26 lymph nodes sampled per patient.
  • 9 procedures were completed on an outpatient basis.

Related Experiment Videos

  • One complication (external vein injury) occurred and was repaired.

    • Conclusions:

    • Outpatient pelvic lymph node dissection via small incisions is a viable alternative to standard and laparoscopic methods.
    • This technique may become preferred for staging prostate cancer, especially in high-risk patients.